CD4 and COVID-19: Although the presence of CD4+ T cells with a cytotoxic phenotype has been reported in both COVID-19 and TB (27, 48), our study specifically identified that LTBI/COVID-19 individuals possess these unconventional CD4+ T cells, which appear to be entirely antigen-specific.